FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1204387005: Product containing precisely sodium valproate 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4955147011 Valproate sodium 333 mg and valproic acid 145 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4955148018 Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5171159017 Product containing precisely sodium valproate 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4955147011 Valproate sodium 333 mg and valproic acid 145 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4955148018 Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4955149014 Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5171159017 Product containing precisely sodium valproate 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Plays role Anticonvulsant therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has precise active ingredient Valproic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has basis of strength substance (attribute) Valproic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has precise active ingredient Sodium valproate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has basis of strength substance (attribute) Sodium valproate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Is a Product containing only valproic acid in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start